Evidence map›Paper›PMID 31974851›Full record

ArticleJournal of computer-aided molecular design2020

D3R grand challenge 4: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energies.

Conor D Parks, Zied Gaieb, Michael Chiu, Huanwang Yang, Chenghua Shao, W Patrick Walters, Johanna M Jansen, Georgia McGaughey, Richard A Lewis, Scott D Bembenek and 5 more

Abstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Evaluating generalization in protein-ligand cofolding methods.Nature structural & molecular biology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Need for Continuing Blinded Pose- and Activity Prediction Benchmarks.Journal of chemical information and modeling · 2025
    Review
  19. MELD in Action: Harnessing Data to Accelerate Molecular Dynamics.Journal of chemical information and modeling · 2025
    Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Conor D ParksDrug Design Data Resource, University of California, San Diego, La Jolla, CA, 92093, USA.
Zied GaiebDrug Design Data Resource, University of California, San Diego, La Jolla, CA, 92093, USA.
Michael ChiuDrug Design Data Resource, University of California, San Diego, La Jolla, CA, 92093, USA.
Huanwang YangRCSB Protein Data Bank, Institute for Quantitative Biomedicine, Rutgers, The State University of New Jersey, New Brunswick, NJ, 08903, USA.
Chenghua ShaoRCSB Protein Data Bank, Institute for Quantitative Biomedicine, Rutgers, The State University of New Jersey, New Brunswick, NJ, 08903, USA.
W Patrick WaltersRelay Therapeutics, Cambridge, MA, 20139, USA.
Johanna M JansenNovartis Institutes for BioMedical Research, Emeryville, CA, 94608, USA.
Georgia McGaugheyVertex Pharmaceuticals Inc, 50 Northern Ave, Boston, MA, 02210, USA.
Richard A LewisNovartis Institutes for BioMedical Research, Novartis Pharma AG, 4002, Basel, Switzerland.
Scott D BembenekDenovicon Therapeutics, San Diego, CA, 92130, USA.
Michael K AmeriksJanssen Research & Development, San Diego, CA, 92121, USA.
Tara MirzadeganJanssen Research & Development, San Diego, CA, 92121, USA.
Stephen K BurleyRCSB Protein Data Bank, Institute for Quantitative Biomedicine, Rutgers, The State University of New Jersey, New Brunswick, NJ, 08903, USA.
Rommie E AmaroDrug Design Data Resource, University of California, San Diego, La Jolla, CA, 92093, USA. drugdesigndata@gmail.com.ORCID 0000-0002-9275-9553
Michael K GilsonDrug Design Data Resource, University of California, San Diego, La Jolla, CA, 92093, USA. mgilson@ucsd.edu.ORCID 0000-0002-3375-1738

Funding

PDB MANAGEMENT BY THE RESEARCH COLLABORATORY FOR STRUCTURAL BIOINFORMATICSR01GM133198 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI BURLEY, STEPHEN K · 2019 to 2023
$19.3M
AN OPEN RESOURCE TO ADVANCE COMPUTER-AIDED DRUG DESIGNU01GM111528 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AMARO, ROMMIE E, GILSON, MICHAEL K. · 2014 to 2018
$3.6M
NIGMS NIH HHS R01 GM133198NIGMS NIH HHS U01 GM111528
6 · The paper itself

Abstract

The Drug Design Data Resource (D3R) aims to identify best practice methods for computer aided drug design through blinded ligand pose prediction and affinity challenges. Herein, we report on the results of Grand Challenge 4 (GC4). GC4 focused on proteins beta secretase 1 and Cathepsin S, and was run in an analogous manner to prior challenges. In Stage 1, participant ability to predict the pose and affinity of BACE1 ligands were assessed. Following the completion of Stage 1, all BACE1 co-crystal structures were released, and Stage 2 tested affinity rankings with co-crystal structures. We provide an analysis of the results and discuss insights into determined best practice methods.

Indexed as

Drug DesignAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesEnzyme InhibitorsHumansLigandsMachine LearningMolecular Docking SimulationSmall Molecule LibrariesThermodynamicsAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesBACE1 protein, humanEnzyme InhibitorsLigandsSmall Molecule LibrariesBlinded prediction challengeD3RDockingFree-energyLigand rankingScoring

Identifiers

PMID31974851
PMCPMC7261493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.